December 2023

NEUROSCIENCES

DISCOVERING NEW ALS THERAPEUTIC AVENUES WITH EVANGELOS KISKINIS, PHD

Featuring: Evangelos Kiskinis, PhD
An estimated 32,000 Americans are currently living with ALS, or amyotrophic lateral sclerosis, a progressive neurodegenerative disease that attacks motor neurons in the brain and spinal cord.

​Northwestern investigators have uncovered novel cellular mechanisms involved in two types of genetic ALS that might lead to future targeted therapies. Evangelos Kiskinis, PhD, shares insights on these findings recently published in Science Advances and Cell Reports. 

“We're at a critical time where we've got this coming together of incredible resources, incredible technologies, and the coming together of the community to make meaningful therapeutics for these ALS patients who have been helpless.”  — Evangelos Kiskinis, PhD 

Continuing Medical Education Credit
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.

Target Audience
Academic/Research, Multiple specialties

Learning Objectives
At the conclusion of this activity, participants will be able to:
  1. Identify the research interests and initiatives of Feinberg faculty.
  2. Discuss new updates in clinical and translational research.

Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Surgery Continuous Certification Program
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

All the relevant financial relationships for these individuals have been mitigated.
Disclosure Statement
Evangelos Kiskinis, PhD, has nothing to disclose. Course director, Robert Rosa, MD, has nothing to disclose. Planning committee member, Erin Spain, has nothing to disclose. FSM’s CME Leadership, Review Committee, and Staff have no relevant financial relationships with ineligible companies to disclose.

​Claim your credit > 

This article was originally published in the Feinberg School of Medicine News Center on December 12, 2023. 
Evangelos Kiskinis, PhD, Associate Professor of Neurology and Neuroscience at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients. 

You May Also Like